SR ONE CAPITAL MANAGEMENT, LLC's Trading History
| ADRXADARx Pharmaceuticals | Sep 29, 2026 | Ten Percent Owner | Uninformative Buy | ― | $168.92M | |
| ODTXOdyssey Therapeutics, Inc. | May 11, 2026 | Ten Percent Owner | Uninformative Buy | 32.04K | $74.15M | |
| AVLNAvalyn Pharma Inc | May 01, 2026 | Ten Percent Owner | Uninformative Buy | ― | $84.80M | |
| ZBIOZenas BioPharma, Inc. | Oct 14, 2025 | Ten Percent Owner | Informative Buy | 2.40M | $143.02M | |
| EFTReFFECTOR Therapeutics | Nov 29, 2023 | Ten Percent Owner | Informative Sell | 365.50K | $124.26K | |
| ACLXArcellx Inc | May 15, 2023 | ― | Informative Sell | 45.59M | $516.34M |
You May Also Like
SR ONE CAPITAL MANAGEMENT, LLC insider profile FAQ
What is the percentage of profitable transactions made by SR ONE CAPITAL MANAGEMENT, LLC?
The percentage of profitable transactions made by SR ONE CAPITAL MANAGEMENT, LLC is 43%.
What is the average return per transaction made by SR ONE CAPITAL MANAGEMENT, LLC?
The average return per transaction made by SR ONE CAPITAL MANAGEMENT, LLC is 5.50%.
What stocks does SR ONE CAPITAL MANAGEMENT, LLC hold?
SR ONE CAPITAL MANAGEMENT, LLC holds: ADRX, EFTR, ACLX, ZBIO, AVLN, ODTX stocks.
What was SR ONE CAPITAL MANAGEMENT, LLC's most profitable transaction?
SR ONE CAPITAL MANAGEMENT, LLC’s most profitable transaction was an Informative Buy of ACLX stock on February 10, 2022. The return on the trade was 80.00%.
What is SR ONE CAPITAL MANAGEMENT, LLC's role in ADARx Pharmaceuticals?
SR ONE CAPITAL MANAGEMENT, LLC's role in ADARx Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.